Pharma companies that make GLP-1 drugs have increasingly promoted telehealth companies that prescribe the popular treatments. With a new deal announced this week, one of those relationships is expected to grow more complicated.
Eli Lilly has been featuring a telehealth company called Counsel Health on a list of providers for patients seeking a GLP-1 prescription.
On Tuesday, Counsel said it would be acquired by the smart ring maker Oura, allowing Counsel clinicians access to the data gathered through the ring so they can help customers understand the data and then diagnose or treat any conditions.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Already have an account? Log in
Individual plans
Group plans
To read the rest of this story subscribe to STAT+.